Presentation
7 March 2022 Monitoring neurodegenerative diseases using paper-based lateral-flow devices
Author Affiliations +
Abstract
Alzheimer’s disease is caused by neurodegeneration resulting in cognitive decline, that has been linked to heightened systemic inflammation. Identification of the characteristic amyloid-β (Aβ) plaques in the brain is either by positron-emission tomography (PET) imaging or through its measurement in cerebrospinal fluid (CSF). A minimally invasive, cost-effective test that measures blood-based biomarker could predict the onset of Alzheimer’s earlier and therefore start therapies to improve patient prognosis. To this end, we have developed lateral-flow tests that measure vascular biomarkers, ICAM-1 and VCAM-1 and have validated their clinical use with serum samples.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alice Iles, Peijun He, Ioannis Katis, Panagiotis Galanis, Jessica Teeling, Robert Eason, and Collin Sones "Monitoring neurodegenerative diseases using paper-based lateral-flow devices", Proc. SPIE PC11940, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic and Photobiomodulation Therapy XXX, (7 March 2022); https://doi.org/10.1117/12.2603877
Advertisement
Advertisement
KEYWORDS
Alzheimer's disease

Brain

Dementia

Multiplexing

Neurodegeneration

Neuroimaging

Neurons

Back to Top